Organogenesis' Pending Acquisition

Organogenesis raised a round of funding on August 17, 2018. Investors include Avista Healthcare Public Acquisition Corp..

Organogenesis provides wound care products for bio-active wound healing and soft tissue regeneration. The portfolio includes FDA-approved Apligraf and Dermagraft, for bio-active wound healing and laun…

Articles about Organogenesis' Pending Acquisition: